BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 3698035)

  • 1. Significance of DNA abnormalities in primary malignant melanoma and nevi, a retrospective flow cytometric study.
    von Roenn JH; Kheir SM; Wolter JM; Coon JS
    Cancer Res; 1986 Jun; 46(6):3192-5. PubMed ID: 3698035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA ploidy in malignant melanoma, skin cancer and pigmented nevi.
    Skowronek J; Adamska K; Filipiak K; Karaś Z; Krenz RM; Rutkowski R; Warchoł JB
    Neoplasma; 1997; 44(5):282-8. PubMed ID: 9473786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric DNA analysis of primary cutaneous malignant melanoma.
    Ohnishi K; Ishikawa H
    Acta Derm Venereol; 1991; 71(6):525-8. PubMed ID: 1685836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of DNA ploidy and degree of DNA abnormality in benign and malignant melanocytic lesions of the skin using video imaging.
    Pilch H; Günzel S; Schäffer U; Tanner B; Heine M
    Cancer; 2000 Mar; 88(6):1370-7. PubMed ID: 10717619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examination of DNA-ploidy in melanocytic nevi cells using video-imaging cytometry.
    Skowronek J; Filipiak K; Karaś Z; Krenz RM; Włodarczyk H
    Pol J Pathol; 1997; 48(1):37-41. PubMed ID: 9200959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of image analysis with flow cytometry for DNA content analysis in pigmented lesions of the skin.
    Sangueza OP; Hyder DM; White CR; Pallander J; Perkins M; Remple N; Bakke A
    Anal Quant Cytol Histol; 1992 Feb; 14(1):55-9. PubMed ID: 1558616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classifying melanocytic tumors based on DNA copy number changes.
    Bastian BC; Olshen AB; LeBoit PE; Pinkel D
    Am J Pathol; 2003 Nov; 163(5):1765-70. PubMed ID: 14578177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinguishing melanocytic nevi from melanoma by DNA copy number changes: comparative genomic hybridization as a research and diagnostic tool.
    Bauer J; Bastian BC
    Dermatol Ther; 2006; 19(1):40-9. PubMed ID: 16405569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathology, morphometry, and nuclear DNA content of iris melanocytic lesions.
    Grossniklaus HE; Oakman JH; Cohen C; Calhoun FP; DeRose PB; Drews-Botsch C
    Invest Ophthalmol Vis Sci; 1995 Mar; 36(3):745-50. PubMed ID: 7890505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is DNA ploidy of prognostic significance in stage I cutaneous melanoma?
    Gattuso P; Reddy V; Solans E; Kathuria S; Aranha GV; Jacobs HK; Walloch J
    Surgery; 1990 Oct; 108(4):702-8; discussion 708-9. PubMed ID: 2218882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applications of DNA flow cytometry and fluorescence in situ hybridization using a chromosome-specific DNA probe on paraffin-embedded tissue sections of primary malignant melanomas.
    Matsuta M; Imamura Y; Matsuta M; Kon S; Sasaki K
    J Dermatol; 1994 Jan; 21(1):14-9. PubMed ID: 8157816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA image cytometry on sections as compared with image cytometry on smears and flow cytometry in melanoma.
    Klapperstück T; Wohlrab W
    Cytometry; 1996 Sep; 25(1):82-9. PubMed ID: 8875057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of melastatin mRNA expression in melanocytic tumors.
    Deeds J; Cronin F; Duncan LM
    Hum Pathol; 2000 Nov; 31(11):1346-56. PubMed ID: 11112208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Favorable prognosis for malignant melanomas associated with acquired melanocytic nevi.
    Friedman RJ; Rigel DS; Kopf AW; Lieblich L; Lew R; Harris MN; Roses DF; Gumport SL; Ragaz A; Waldo E; Levine J; Levenstein M; Koenig R; Bart RS; Trau H
    Arch Dermatol; 1983 Jun; 119(6):455-62. PubMed ID: 6859885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The importance of flow cytometry and the cell proliferation index in choroidal melanoma].
    Ranty ML; Quintyn JC; Courville P; Brasseur G
    J Fr Ophtalmol; 2003 Sep; 26(7):725-9. PubMed ID: 13130261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA aneuploidy in congenital melanocytic nevi: suggestive evidence for premalignant changes.
    Stenzinger W; Suter L; Schumann J
    J Invest Dermatol; 1984 Jun; 82(6):569-72. PubMed ID: 6725981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of DNA ploidy measurements in Spitz nevi.
    Skowronek J; Warchoł JB; Karaś Z; Krenz RM
    Pol J Pathol; 2000; 51(1):45-50. PubMed ID: 10833903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follow-up of melanocytic skin lesions with digital epiluminescence microscopy: patterns of modifications observed in early melanoma, atypical nevi, and common nevi.
    Kittler H; Pehamberger H; Wolff K; Binder M
    J Am Acad Dermatol; 2000 Sep; 43(3):467-76. PubMed ID: 10954658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoreactivity with the anti-MAGE antibody 57B in malignant melanoma: frequency of expression and correlation with prognostic parameters.
    Busam KJ; Iversen K; Berwick M; Spagnoli GC; Old LJ; Jungbluth AA
    Mod Pathol; 2000 Apr; 13(4):459-65. PubMed ID: 10786815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. bcl-2 protein expression in melanocytic neoplasms of the skin.
    Ramsay JA; From L; Kahn HJ
    Mod Pathol; 1995 Feb; 8(2):150-4. PubMed ID: 7777475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.